Editorial Board
Journal of ImmunoTherapy of Cancer Editorial Board members have agreed and adhere to the BMJ Editor Roles and Responsibilities guidelines; including our Editor policy on competing interests.
Deputy Editor-in-Chief
James L. Gulley, MD, PhD, FACP
National Cancer Institute, National Institutes of Health, United States
Declaration of Interests
Basic Tumor Immunology
Section Editor
Cornelis J. M. Melief, MD, PhD
Leiden University Medical Center, the Netherlands
Leiden University Medical Center, the Netherlands
Sjoerd H. van der Burg, PhD
Leiden University Medical Center, the Netherlands
orcid.org/0000-0002-6556-0354
Leiden University Medical Center, the Netherlands
orcid.org/0000-0002-6556-0354
Associate Editors
Scott I. Abrams, PhD
Roswell Park Cancer Institute, United States
Roswell Park Cancer Institute, United States
Timothy NJ Bullock, PhD
University of Virginia, United States
orcid.org/0000-0001-6141-3261
Gennaro Ciliberto, MD
IRCCS Istituto Nazionale Tumori Regina Elena, Italy
orcid.org/0000-0003-2851-8605
Khashayarsha Khazaie, PhD, DSc
Mayo Clinic College of Medicine, United States
Mayo Clinic College of Medicine, United States
Eric Tartour, MD, PhD
Hôpital Européen Georges Pompidou, France
Viktor Umansky, PhD
German Cancer Research Center (DKFZ), Germany
Case Reports
Section Editor
Associate Editors
Jack D. Bui, MD, PhD
University of California San Diego, United States
orcid.org/0000-0002-9324-368X
Sebastian Kobold, MD
Klinikum der Universität München, Germany
Heinz Läubli, MD, PhD
University Hospital Basel, Switzerland
orcid.org/0000-0002-8910-5620
Clinical/Translational Cancer Immunotherapy
Section Editors
Douglas G. McNeel, MD, PhD
University of Wisconsin Carbone Cancer Center, United States
orcid.org/0000-0003-1471-6723
Claudia Palena, PhD
National Cancer Institute, National Institutes of Health, United States
Jeffrey S. Weber, MD, PhD
New York University Langone Medical Center, United States
orcid.org/0000-0002-4962-2957
Associate Editors
Paolo Antonio Ascierto, MD
Istituto Nazional Tumori-Fondazione ‘G.Pascale’, Italy
orcid.org/0000-0002-8322-475X
Richard D. Carvajal, MD
Columbia University Irving Medical Center, United States
Tanja D. de Gruijl, PhD
Amsterdam University Medical Centers, the Netherlands
orcid.org/0000-0003-1464-8978
Brian R. Gastman, MD
Cleveland Clinic Cancer Center, United States
Margaret E. Gatti-Mays, MD, MPH
Ohio State University Comprehensive Cancer Center, United States
orcid.org/0000-0001-8914-2897
Christian S. Hinrichs, MD
Rutgers Cancer Institute of New Jersey, United States
orcid.org/0000-0001-5597-2841
Hongbo Hu, PhD
West China Hospital, Sichuan University, China
Douglas B. Johnson, MD, MSCI
Vanderbilt University Medical Center, United States
Pawel Kalinski, MD, PhD
Roswell Park Cancer Institute, United States
Dung Le, MD
Johns Hopkins University, United States
Yangqiu Li, MD
Jinan University School of Medicine, China
Jason J. Luke, MD, FACP
University of Pittsburgh Medical Center, United States
orcid.org/0000-0002-1182-4908
Ravi A. Madan, MD
National Cancer Institute, National Institutes of Health, United States
orcid.org/0000-0001-5106-8636
Luca Mazzarella, MD, PhD
European Institute of Oncology, Italy
orcid.org/0000-0002-4043-3279
Anna Obenauf, PhD
Research Institute of Molecular Pathology, Austria
Ravi Patel, MD, PhD
University of Pittsburgh, United States
orcid.org/0000-0002-8328-746X
Clinical Trials Monitor
Section Editor
Leisha A. Emens, MD, PhD
UPMC Hillman Cancer Center, United States
orcid.org/0000-0002-7694-0731
Associate Editors
Tai-Tsang Chen, PhD
Columbia University; Bristol-Myers Squibb, United States
Jolanda de Vries, PhD
Radboud University Nijmegen, the Netherlands
Larry W. Kwak, MD, PhD
City of Hope, United States
orcid.org/0000-0002-1884-5349
Kunle Odunsi, MD, PhD
University of Chicago Medicine Comprehensive Cancer Center, United States
Louis M. Weiner, MD
Georgetown-Lombardi Comprehensive Cancer Center, United States
orcid.org/0000-0001-5192-0710
Commentary/Editorials
Section Editor
Christian M. Capitini, MD
University of Wisconsin, Madison, United States
orcid.org/0000-0002-2276-6731
Associate Editors
Ana Carrizosa Anderson, MD
Harvard University, United States
orcid.org/0000-0002-0877-2932
Bryon D. Johnson, PhD
Medical College of Wisconsin, United States
William J. Murphy, PhD
University of California, Davis, United States
orcid.org/0000-0002-2793-401X
Gabriel Rabinovich, PhD
Instituto de Biologia y Medicina Experimental (IByME), Argentina
orcid.org/0000-0002-0947-8735
William L. Redmond, PhD
Earle A. Chiles Research Institute, United States
orcid.org/0000-0002-2572-1731
Geoffrey R. Weiss, MD
University of Virginia, United States
orcid.org/0000-0001-8226-5552
Guidelines and Consensus Statements
Section Editor
Robert L. Ferris, MD, PhD
University of Pittsburgh Cancer Institute, United States
orcid.org/0000-0001-6605-2071
Associate Editors
Michael B. Atkins, MD
Georgetown-Lombardi Comprehensive Cancer Center, United States
orcid.org/0000-0003-3901-9924
Michael Platten, MD
Ruprecht-Karls University Heidelberg, Germany
orcid.org/0000-0002-4746-887X
Immune Cell Therapies and Immune Cell Engineering
Section Editor
Marcela V. Maus, MD, PhD
Massachusetts General Hospital, United States
Associate Editors
Aude Chapuis, MD
Fred Hutchinson Cancer Research Center, United States
Yvonne Y. Chen, PhD
University of California, Los Angeles, United States
orcid.org/0000-0002-5583-119X
Marco L. Davila, MD, PhD
H. Lee Moffitt Cancer Center, United States
orcid.org/0000-0002-6270-3065
Jennifer L. Guerriero, PhD
Brigham and Women’s Hospital, United States
orcid.org/0000-0002-2104-5457
Gerald Linette, MD, PhD
University of Pennsylvania, United States
orcid.org/0000-0001-6147-6115
Daniel J. Powell, Jr., PhD
University of Pennsylvania, United States
orcid.org/0000-0002-5966-8908
Marco Ruella, MD
University of Pennsylvania, United States
orcid.org/0000-0003-4301-5811
Lillian Seu, PhD
Vir Biotechnology, United States
orcid.org/0000-0002-8456-019X
Nirali N. Shah, MD, MHSc
National Cancer Institute, National Institutes of Health, United States
orcid.org/0000-0002-8474-9080
Eric L. Smith, MD, PhD
Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, United States
orcid.org/0000-0002-0296-7587
Immunotherapy Biomarkers
Section Editor
Ignacio Melero, MD, PhD
University of Navarra, Spain
orcid.org/0000-0002-1360-348X
Alexandra Snyder Charen, MD
Generate Biomedicines, United States
orcid.org/0000-0002-2606-3523
Deputy Editor
Kurt Schalper, MD, PhD
Yale School of Medicine, United States
Associate Editors
Maria Ascierto, PhD
AstraZeneca, United States
John C. Castle, PhD
Agenus, Germany
orcid.org/0000-0001-8697-8955
Alessandra Cesano, MD, PhD
ESSA Pharma Inc., United States
Eric Deutsch, MD, PhD
Gustave Roussy Cancer Campus, France
Michael D. Kalos, PhD
Arsenal Biosciences, United States
Rejean Lapointe, PhD
Universite De Montreal, University Hospital (CRCHUM), Canada
Sanjeev Mariathasan, PhD
Genentech, United States
Christian H. Ottensmeier, MD, PhD, FRCP
University of Liverpool, United Kingdom
Graham P. Pawelec, PhD
University of Tuebingen, Germany
orcid.org/0000-0002-3600-0163
Mohini Rajasagi, PhD
Merck & Co., United States
Licia Rivoltini, MD
Fondazione IRCCS Istituto Nazionale Tumori, Italy
Barbara Seliger, MD, PhD
Martin Luther University Halle-Wittenberg, Germany
orcid.org/0000-0002-5544-4958
Craig L. Slingluff Jr., MD
University of Virginia, United States
orcid.org/0000-0002-6664-4373
Jianda Yuan, MD, PhD
Merck & Co., United States
orcid.org/0000-0003-3551-4434
Oncolytic and Local Immunotherapy
Section Editor
Howard L. Kaufman, MD, FACS
Massachusetts General Hospital, United States
orcid.org/0000-0003-1131-004X
Associate Editors
John C. Bell, PhD
Ottawa Hospital Research Institute, Canada
orcid.org/0000-0002-9083-357X
Kevin Harrington, PhD, FRCP, FRCR
The Institute of Cancer Research, United Kingdom
orcid.org/0000-0002-6014-348X
Samuel Rabkin, PhD
Massachusetts General Hospital, United States
orcid.org/0000-0003-2344-2795
Stephen J. Russell, MD, PhD
Mayo Clinic College of Medicine, United States
Ann W. Silk, MD, MS
Dana-Farber Cancer Institute, United States
orcid.org/0000-0003-3877-3984
Dmitriy Zamarin, MD, PhD
Memorial Sloan Kettering Cancer Center, United States
orcid.org/0000-0002-0094-0161
Reviews
Section Editors
Sandra Demaria, MD
Weill Cornell Medical College, United States
orcid.org/0000-0003-4426-0499
Lawrence Fong, MD
University of California, San Francisco, United States
Associate Editors
Michael B. Atkins, MD
Georgetown-Lombardi Comprehensive Cancer Center, United States
orcid.org/0000-0003-3901-9924
Ira Mellman, PhD
Genentech, United States
orcid.org/0000-0002-6132-7299
James J. Mule, PhD
H. Lee Moffitt Cancer Center & Research Institute, United States
orcid.org/0000-0001-7354-0516
Social Media and Consulting Editors
Social Media Associate Editor
Cheng Sun, MD, PhD
University of Science and Technology of China, China
Consulting Editor
Thomas F. Gajewski, MD, PhD
University of Chicago, United States
Publishing Team
Publisher: Kathleen Lyons